Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      1. Home
        /
      2. Our Company
        /
      3. Our societal impact
        /
      4. Global Health Equity
      5. /
        It’s time to end drug-resistant tuberculosis: The case for action
      Dr. Anna Vassall of the London School of Hygiene & Tropical Medicine discussing the "The Cost of Complacency", a 2019 report from the Economist Intelligence Unit
      Global Health Equity

      It’s time to end drug-resistant tuberculosis: The case for action

      May 9, 2019
      May 9, 2019

      A new report published by The Economist Intelligence Unit (EIU), and with support from Johnson & Johnson, emphasizes the urgent need for focused global action to address the growing threat of DR-TB. Through innovative partnerships and collaborations, Johnson & Johnson is working to create world without DR-TB and end TB.

      Learn more about the report here.